Transition of Serotype 35B Pneumococci From Commensal to Prevalent Virulent Strain in Children

Naoko Fuji1, Michael Pichichero1, Rachel L Ehrlich2

  • 1Center for Infectious Diseases and Immunology, Rochester General Hospital Research Institute, Rochester, NY, United States.

Insights

Pneumococcal serotype 35B shifted from a common nasal bacteria to a leading cause of acute otitis media in children starting in 2015. This change was linked to genetic alterations and increased antibiotic resistance in 35B strains.

Area of Science:

  • Microbiology
  • Genomics
  • Epidemiology

Background:

  • Pneumococcal serotype 35B was historically a commensal nasopharyngeal bacterium in young children.
  • A shift in virulence and disease association for serotype 35B was observed starting in 2015.

Purpose of the Study:

  • To investigate the genomic and antibiotic resistance changes in pneumococcal serotype 35B associated with increased acute otitis media (AOM) incidence.
  • To compare 35B isolates from before and after the observed shift in virulence.

Main Methods:

  • Comparative analysis of 250 pneumococcal serotype 35B isolates from children (2006-2019).
  • Whole-genome sequencing of 72 isolates to identify genetic variations.
  • Analysis of prevalence, clonal composition, and antibiotic resistance (MIC50).

Main Results:

  • Pneumococcal serotype 35B strains, particularly those belonging to sequence type 558 (ST558), became associated with increased AOM starting in 2015.
  • Significant increases in resistance to beta-lactams and ofloxacin were observed, especially in 35B/ST558 isolates after 2015.
  • One hundred thirty-eight single nucleotide polymorphisms (SNPs) in 34 genes, including those involved in metal transport and DNA replication, were associated with post-2015 strains.

Conclusions:

  • Pneumococcal serotype 35B evolved from a common commensal to a significant cause of pediatric AOM due to genetic changes.
  • The genetic modifications in 35B strains correlate with increased virulence and altered antibiotic susceptibility, driving the rise in AOM cases.